Samsara BioCapital, LLC

Q1 2026 13F-HR Holdings

Location
Palo Alto, CA
Holdings as of
3/31/2026
Date filed
5/15/2026
Form type
13F-HR
Num holdings
22
Total value ($000)
$1,029,103
Net value change ($000)
+59,846 (6.2%)
New positions
3
Sold out positions
1
Turnover %
6.6%
Sector allocation + QoQ delta (equities-only)
Prev filing: 2/17/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q4 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ALMS 83,597 148.8%
SGP 54,669 NEW
SRRK 35,247 11.6%
STRO 24,110 1019.0%
AGMB 6,294 NEW
CHRS 5,794 NEW
IVA 4,675 19.4%
ACLX 3,020 76.1%
NKTX 912 14.1%
Top Reduces (Value $000, Stocks/ETFs)
MLYS -54,013 -25.4%
KLRS -34,572 -31.6%
GOSS -20,017 -89.4%
UPB -13,360 -66.9%
SEPN -12,124 -13.8%
PVLA -6,180 -56.3%
AQST -5,775 -35.8%
RANI -5,229 -45.6%
ABVX -3,874 -38.1%
JBIO -1,337 -8.9%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type